4D Molecular Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of unlocking the full potential of genetic medicines to treat large market diseases in ophthalmology and pulmonology. The firm also offers product candidates focused on large market ophthalmology, pulmonology, and cardiology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bizily Scott | Chief Legal Officer | May 16 '24 | Option Exercise | 7.60 | 1,750 | 13,295 | 3,487 | May 20 08:35 PM | Bizily Scott | Chief Legal Officer | May 16 '24 | Sale | 25.45 | 1,750 | 44,541 | 1,737 | May 20 08:35 PM | Bizily Scott | Chief Legal Officer | Apr 16 '24 | Option Exercise | 7.60 | 1,750 | 13,295 | 3,487 | Apr 18 08:48 PM | Bizily Scott | Chief Legal Officer | Apr 16 '24 | Sale | 25.74 | 1,750 | 45,045 | 1,737 | Apr 18 08:48 PM | Bizily Scott | Chief Legal Officer | Apr 01 '24 | Option Exercise | 12.54 | 8,153 | 102,224 | 9,890 | Apr 03 07:18 PM | Bizily Scott | Chief Legal Officer | Apr 01 '24 | Sale | 31.78 | 8,153 | 259,102 | 1,737 | Apr 03 07:18 PM | Bizily Scott | Chief Legal Officer | Mar 27 '24 | Option Exercise | 25.98 | 5,833 | 151,541 | 7,570 | Mar 29 04:52 PM | Bizily Scott | Chief Legal Officer | Mar 27 '24 | Sale | 35.04 | 5,833 | 204,410 | 1,737 | Mar 29 04:52 PM | Bizily Scott | Chief Legal Officer | Mar 18 '24 | Option Exercise | 7.60 | 1,750 | 13,295 | 3,487 | Mar 20 04:40 PM | Bizily Scott | Chief Legal Officer | Mar 18 '24 | Sale | 31.27 | 1,750 | 54,722 | 1,737 | Mar 20 04:40 PM | Bizily Scott | Chief Legal Officer | Feb 27 '24 | Option Exercise | 20.24 | 1,909 | 38,638 | 3,646 | Feb 29 06:01 PM | Bizily Scott | Chief Legal Officer | Feb 27 '24 | Sale | 30.00 | 1,909 | 57,270 | 1,737 | Feb 29 06:01 PM | Bizily Scott | Chief Legal Officer | Feb 16 '24 | Option Exercise | 7.60 | 1,750 | 13,295 | 3,487 | Feb 21 05:41 PM | Bizily Scott | Chief Legal Officer | Feb 16 '24 | Sale | 27.67 | 1,750 | 48,422 | 1,737 | Feb 21 05:41 PM | Bizily Scott | Chief Legal Officer | Feb 08 '24 | Option Exercise | 10.18 | 6,244 | 63,586 | 4,653 | Feb 12 09:04 PM | Kirn David | Chief Executive Officer | Feb 08 '24 | Sale | 27.13 | 92,001 | 2,495,822 | 1,059,153 | Feb 12 08:22 PM | Bizily Scott | Chief Legal Officer | Feb 08 '24 | Sale | 27.50 | 6,244 | 171,710 | 1,737 | Feb 12 09:04 PM | Kim Robert Young | Chief Medical Officer | Feb 05 '24 | Option Exercise | 15.29 | 24,000 | 366,840 | 13,595 | Feb 07 08:32 PM | Kim Robert Young | Chief Medical Officer | Feb 05 '24 | Sale | 30.05 | 24,552 | 737,788 | 1,043 | Feb 07 08:32 PM | Kirn David | Chief Executive Officer | Jan 23 '24 | Sale | 18.41 | 5,696 | 104,851 | 1,151,154 | Jan 25 04:59 PM | Kirn David | Chief Executive Officer | Jan 05 '24 | Sale | 19.57 | 28,237 | 552,478 | 1,156,850 | Jan 08 04:19 PM | VIKING GLOBAL INVESTORS LP | 10% Owner | Jan 04 '24 | Sale | 19.53 | 540,000 | 10,546,200 | 4,247,914 | Jan 05 05:44 PM | Kirn David | Chief Executive Officer | Jan 04 '24 | Sale | 20.31 | 40,732 | 827,202 | 1,185,087 | Jan 08 04:19 PM | Kirn David | Chief Executive Officer | Dec 18 '23 | Sale | 18.13 | 4,702 | 85,243 | 1,225,819 | Jan 08 04:19 PM | Kirn David | Chief Executive Officer | Dec 15 '23 | Sale | 17.27 | 28,632 | 494,432 | 1,230,521 | Jan 08 04:19 PM | Bizily Scott | Chief Legal and HR Officer | Jun 08 '23 | Option Exercise | 8.04 | 3,750 | 30,150 | 5,487 | Jun 12 06:23 PM | Bizily Scott | Chief Legal and HR Officer | Jun 08 '23 | Sale | 20.85 | 3,750 | 78,188 | 1,737 | Jun 12 06:23 PM | Bizily Scott | Chief Legal and HR Officer | Jun 01 '23 | Option Exercise | 6.49 | 1,875 | 12,169 | 3,984 | Jun 06 07:23 PM | Bizily Scott | Chief Legal and HR Officer | Jun 01 '23 | Sale | 18.31 | 2,247 | 41,143 | 1,737 | Jun 06 07:23 PM |
|